Jack Allen
Stock Analyst at Baird
(0)
# 4761
Out of 5,270 analysts
48
Total ratings
32.35%
Success rate
-23.16%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CARISMA Therapeutics | Downgrades: Neutral | 10 1 | 0.4 | 150% | 3 | Dec 12, 2024 | |
MiNK Therapeutics | Maintains: Outperform | 8 4 | 8.5 | -52.94% | 2 | Nov 15, 2024 | |
Vor Biopharma | Maintains: Outperform | 22 14 | 0.97 | 1343.3% | 3 | Nov 8, 2024 | |
Arcellx | Maintains: Outperform | 77 106 | 62.66 | 69.17% | 5 | Nov 6, 2024 | |
Intellia Therapeutic... | Maintains: Neutral | 24 18 | 9.45 | 90.48% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 180 180 | 18.13 | 892.83% | 9 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 120 | 3.9 | 2976.92% | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 2.33 | 243.35% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 52 | 42.26 | 23.05% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 84 | 28.89 | 190.76% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 200 25 | n/a | n/a | 3 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 8 | 1.6 | 400% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 21 6 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 12 | 1.8 | 566.67% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 0.52 | 861.54% | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | n/a | n/a | 1 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 28 | 1.01 | 2672.28% | 1 | Jun 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 9 | 3.9 | 130.77% | 1 | Oct 7, 2021 |